EPO Berlin-Buch GmbH
University / Research Organisation
www.epo-berlin.comBerlin, GermanyAbout
EPO is a preclinical contract research organization (CRO) offering customized pre-clinical oncology and immuno-oncology services for the development of novel anti-cancer drugs.
Our portfolio includes >1000 well characterized PDX models, cell line-derived xenograft- as well as syngeneic tumor models. EPO also has long term experience in the establishment of humanized models and has been running studies in these for over a decade.
EPO has been founded in 1997 as a spin-off from the MDC in Berlin-Buch.
Disease Area
Cancer
Biomedical Research, Medicine, Human Health
Drug Target DiscoveryBiomarker DiscoveryCell TherapyRNA-based Therapy
Technology
Data science, AI / Machine learningPersonalized disease models
Representatives
Head of Business Development
EPO Berlin-Buch GmbH